Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Parasites and Immunotherapy: With or Against? Publisher



Yousofi Darani H1 ; Yousefi M2 ; Safari M3 ; Jafari R4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Student Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran
  3. 3. Department of Medical Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
  4. 4. Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Parasitic Diseases Published:2016


Abstract

Immunotherapy is a sort of therapy in which antibody or antigen administrates to the patient in order to treat or reduce the severity of complications of disease. This kind of treatment practiced in a wide variety of diseases including infectious diseases, autoimmune disorders, cancers and allergy. Successful and unsuccessful immunotherapeutic strategies have been practiced in variety of parasitic infections. On the other hand parasites or parasite antigens have also been considered for immunotherapy against other diseases such as cancer, asthma and multiple sclerosis. In this paper immunotherapy against common parasitic infections, and also immunotherapy of cancer, asthma and multiple sclerosis with parasites or parasite antigens have been reviewed. © 2014, Indian Society for Parasitology.
Related Docs
View other Related Docs
1. Parasites and Cancers: Parasite Antigens As Possible Targets for Cancer Immunotherapy, Future Oncology (2012)
2. Effect of Hydatid Cyst Antigens Polyspecific Antisera on Breast Cancer Cells (4T1) Growth in Cell Culture Medium, International Journal of Environmental Health Engineering (2022)
3. Low Titer of Antibody Against Toxoplasma Gondii May Be Related to Resistant to Cancer, Journal of Cancer Research and Therapeutics (2015)
4. Mutual Action of Anticancer and Antiparasitic Drugs: Are There Any Shared Targets?, Future Oncology (2014)
5. Parasites As Potential Targets for Cancer Immunotherapy, Journal of Cancer Research and Clinical Oncology (2023)
6. Anti-Cancer Immunoprotective Effects of Immunization With Hydatid Cyst Wall Antigens in a Non-Immunogenic and Metastatic Triple-Negative Murine Mammary Carcinoma Model, International Immunopharmacology (2021)
7. Effect of Alive Protoscoleces of Hydatid Cyst on the Growth of Melanoma Cells in Mouse Model, Journal of Isfahan Medical School (2014)
8. Vaccination in Leishmaniasis: A Review Article, Iranian Biomedical Journal (2022)
Experts (# of related papers)
View all Related Experts
Hossein Yousofi Darani (16)
Mohammad Reza Mofid (4)
Other Related Docs
9. Effect of Two Hydatid Cyst Antigens on the Growth of Melanoma Cancer in C57/Black Mice, Journal of Parasitic Diseases (2016)
10. Identifying the Most Effective Hydatid Cyst Fluid Fraction for Anticancer Vaccination of 4T1 Breast Tumor-Bearing Mice, International Journal of Preventive Medicine (2019)
11. Inhibition of Mouse Colon Cancer Growth Following Immunotherapy With a Fraction of Hydatid Cyst Fluid, Experimental Parasitology (2023)
12. Monoclonal Antibodies Production Against a 40Kda Band of Hydatid Cyst Fluid, Recent Patents on Biotechnology (2018)
13. Effects of Toxoplasma Gondii and Toxocara Canis Antigens on Wehi-164 Fibrosarcoma Growth in a Mouse Model, Korean Journal of Parasitology (2009)
14. Anti-Toxoplasma Gondii Antibodies Attach to Mouse Cancer Cell Lines But Not Normal Mouse Lymphocytes, Biomedical Reports (2019)
15. Effect of Hydatid Cyst Antigens on Inhibition of Melanoma Cancer Growth in Mouse Model, Cellular and Molecular Biology (2018)
16. A Systematic Review of Toxoplasma Gondii Antigens to Find the Best Vaccine Candidates for Immunization, Microbial Pathogenesis (2019)
17. Review of the Prevalence and Causes of Antimony Compounds Resistance in Different Societies: Review Article, Tehran University Medical Journal (2017)
18. The Seroprevalence of Anti-Toxoplasma Gondii Igg and Igm Antibodies in Serum Samples Referred to Educational Hospitals of Abadan, Journal of Isfahan Medical School (2022)
19. Evaluation of Th17 Immune Responses of Recombinant Dna Vaccine Encoding Gra14 and Rop13 Genes Against Toxoplasma Gondii in Balb/C Mice, Infection, Genetics and Evolution (2021)
20. Serological Evaluation of Anti-Toxoplasma Gondii Antibodies in Patients With Acute Leukemia and Lymphoma Through Chemotherapy, Iranian Journal of Parasitology (2020)
21. Detection of Toxoplasma Gondi in Acute and Chronic Phases of Infection in Immunocompromised Patients and Pregnant Women With Real-Time Pcr Assay Using Taqman Fluorescent Probe, Iranian Journal of Parasitology (2018)
22. Prevalence of Toxoplasma Gondii and the Level of Il8 in Patients With Celiac Disease, Koomesh (2016)
23. Investigating the Reaction of Antisera Against Hydatid Cyst Antigens With the Surface of Breast Cancer (4T1), Melanoma (B16f10), and Normal Spleen Cells Using Flow Cytometry Technique, Journal of Isfahan Medical School (2018)
24. Randomised Vaccine Trial of Single Dose of Killed Leishmania Major Plus Bcg Against Anthroponotic Cutaneous Leishmaniasis in Bam, Iran, Lancet (1998)
25. Frequency of Blood-Tissue Parasitic Infections in Patients With Multiple Sclerosis, As Compared to Their Family Members, International Journal of Preventive Medicine (2014)
26. Detection of Toxoplasma Parasitemia by Pcr: Does It Correlate With Igg and Igm Antibody Titers?, Iranian Journal of Immunology (2006)
27. Seroprevalence of Toxocaracanis in Asthmatic Children and Its Relation to the Severity of Diseases - a Case-Control Study, Medical archives (Sarajevo, Bosnia and Herzegovina) (2018)
28. Human Anti-Toxoplasma Antibodies Attach Strongly to Breast Cancer Cells, International Journal of Cancer Management (2023)